Heterocyclic compound
The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superio...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ISHICHI YUJI RHIM CHUL YUN JEON HYE SUN YOGO TAKATOSHI YOON CHEOLHWAN YOSHIDA MASATO MARUI SHOGO ODA TSUNEO SUZUKI HIDEO KIM KWANG OK NAGAMIYA HIROYUKI KUSUMOTO TOMOKAZU KANG HYUN BIN SETO MASAKI LEE GIL NAM |
| description | The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9085578B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9085578B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9085578B23</originalsourceid><addsrcrecordid>eNrjZBD1SC1JLcpPrkzOyUxWSM7PLcgvzUvhYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWBhampuYWTkbGRCgBAFbLIUU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Heterocyclic compound</title><source>esp@cenet</source><creator>ISHICHI YUJI ; RHIM CHUL YUN ; JEON HYE SUN ; YOGO TAKATOSHI ; YOON CHEOLHWAN ; YOSHIDA MASATO ; MARUI SHOGO ; ODA TSUNEO ; SUZUKI HIDEO ; KIM KWANG OK ; NAGAMIYA HIROYUKI ; KUSUMOTO TOMOKAZU ; KANG HYUN BIN ; SETO MASAKI ; LEE GIL NAM</creator><creatorcontrib>ISHICHI YUJI ; RHIM CHUL YUN ; JEON HYE SUN ; YOGO TAKATOSHI ; YOON CHEOLHWAN ; YOSHIDA MASATO ; MARUI SHOGO ; ODA TSUNEO ; SUZUKI HIDEO ; KIM KWANG OK ; NAGAMIYA HIROYUKI ; KUSUMOTO TOMOKAZU ; KANG HYUN BIN ; SETO MASAKI ; LEE GIL NAM</creatorcontrib><description>The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150721&DB=EPODOC&CC=US&NR=9085578B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150721&DB=EPODOC&CC=US&NR=9085578B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ISHICHI YUJI</creatorcontrib><creatorcontrib>RHIM CHUL YUN</creatorcontrib><creatorcontrib>JEON HYE SUN</creatorcontrib><creatorcontrib>YOGO TAKATOSHI</creatorcontrib><creatorcontrib>YOON CHEOLHWAN</creatorcontrib><creatorcontrib>YOSHIDA MASATO</creatorcontrib><creatorcontrib>MARUI SHOGO</creatorcontrib><creatorcontrib>ODA TSUNEO</creatorcontrib><creatorcontrib>SUZUKI HIDEO</creatorcontrib><creatorcontrib>KIM KWANG OK</creatorcontrib><creatorcontrib>NAGAMIYA HIROYUKI</creatorcontrib><creatorcontrib>KUSUMOTO TOMOKAZU</creatorcontrib><creatorcontrib>KANG HYUN BIN</creatorcontrib><creatorcontrib>SETO MASAKI</creatorcontrib><creatorcontrib>LEE GIL NAM</creatorcontrib><title>Heterocyclic compound</title><description>The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD1SC1JLcpPrkzOyUxWSM7PLcgvzUvhYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWBhampuYWTkbGRCgBAFbLIUU</recordid><startdate>20150721</startdate><enddate>20150721</enddate><creator>ISHICHI YUJI</creator><creator>RHIM CHUL YUN</creator><creator>JEON HYE SUN</creator><creator>YOGO TAKATOSHI</creator><creator>YOON CHEOLHWAN</creator><creator>YOSHIDA MASATO</creator><creator>MARUI SHOGO</creator><creator>ODA TSUNEO</creator><creator>SUZUKI HIDEO</creator><creator>KIM KWANG OK</creator><creator>NAGAMIYA HIROYUKI</creator><creator>KUSUMOTO TOMOKAZU</creator><creator>KANG HYUN BIN</creator><creator>SETO MASAKI</creator><creator>LEE GIL NAM</creator><scope>EVB</scope></search><sort><creationdate>20150721</creationdate><title>Heterocyclic compound</title><author>ISHICHI YUJI ; RHIM CHUL YUN ; JEON HYE SUN ; YOGO TAKATOSHI ; YOON CHEOLHWAN ; YOSHIDA MASATO ; MARUI SHOGO ; ODA TSUNEO ; SUZUKI HIDEO ; KIM KWANG OK ; NAGAMIYA HIROYUKI ; KUSUMOTO TOMOKAZU ; KANG HYUN BIN ; SETO MASAKI ; LEE GIL NAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9085578B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ISHICHI YUJI</creatorcontrib><creatorcontrib>RHIM CHUL YUN</creatorcontrib><creatorcontrib>JEON HYE SUN</creatorcontrib><creatorcontrib>YOGO TAKATOSHI</creatorcontrib><creatorcontrib>YOON CHEOLHWAN</creatorcontrib><creatorcontrib>YOSHIDA MASATO</creatorcontrib><creatorcontrib>MARUI SHOGO</creatorcontrib><creatorcontrib>ODA TSUNEO</creatorcontrib><creatorcontrib>SUZUKI HIDEO</creatorcontrib><creatorcontrib>KIM KWANG OK</creatorcontrib><creatorcontrib>NAGAMIYA HIROYUKI</creatorcontrib><creatorcontrib>KUSUMOTO TOMOKAZU</creatorcontrib><creatorcontrib>KANG HYUN BIN</creatorcontrib><creatorcontrib>SETO MASAKI</creatorcontrib><creatorcontrib>LEE GIL NAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ISHICHI YUJI</au><au>RHIM CHUL YUN</au><au>JEON HYE SUN</au><au>YOGO TAKATOSHI</au><au>YOON CHEOLHWAN</au><au>YOSHIDA MASATO</au><au>MARUI SHOGO</au><au>ODA TSUNEO</au><au>SUZUKI HIDEO</au><au>KIM KWANG OK</au><au>NAGAMIYA HIROYUKI</au><au>KUSUMOTO TOMOKAZU</au><au>KANG HYUN BIN</au><au>SETO MASAKI</au><au>LEE GIL NAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Heterocyclic compound</title><date>2015-07-21</date><risdate>2015</risdate><abstract>The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US9085578B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Heterocyclic compound |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A02%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ISHICHI%20YUJI&rft.date=2015-07-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9085578B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |